18.61
Schlusskurs vom Vortag:
$17.54
Offen:
$17.46
24-Stunden-Volumen:
273.50K
Relative Volume:
0.82
Marktkapitalisierung:
$345.50M
Einnahmen:
$62.81M
Nettoeinkommen (Verlust:
$-13.75M
KGV:
-23.26
EPS:
-0.8
Netto-Cashflow:
$153.00K
1W Leistung:
+2.08%
1M Leistung:
+44.71%
6M Leistung:
+252.46%
1J Leistung:
+147.14%
Optimizerx Corp Stock (OPRX) Company Profile
Firmenname
Optimizerx Corp
Sektor
Branche
Telefon
248-651-6558
Adresse
260 CHARLES STREET, WALTHAM, MI
Vergleichen Sie OPRX mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
OPRX
Optimizerx Corp
|
18.61 | 318.58M | 62.81M | -13.75M | 153.00K | -0.80 |
![]()
VEEV
Veeva Systems Inc
|
270.06 | 44.25B | 2.97B | 809.93M | 1.33B | 4.87 |
![]()
TEM
Tempus Ai Inc
|
78.12 | 13.61B | 803.32M | -709.10M | -212.68M | -7.8003 |
![]()
DOCS
Doximity Inc
|
68.52 | 12.55B | 550.17M | 201.35M | 232.07M | 1.00 |
![]()
HQY
Healthequity Inc
|
97.70 | 7.68B | 1.15B | 96.70M | -161.99M | 1.09 |
![]()
WAY
Waystar Holding Corp
|
37.23 | 6.45B | 906.14M | -52.62M | 89.62M | -0.3621 |
Optimizerx Corp Stock (OPRX) Upgrades & Downgrades
Datum | Aktion | Analytiker | Ratingänderung |
---|---|---|---|
2025-01-08 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
2024-12-20 | Eingeleitet | Stephens | Equal-Weight |
2024-07-25 | Fortgesetzt | B. Riley Securities | Buy |
2024-04-04 | Eingeleitet | JMP Securities | Mkt Outperform |
2024-01-03 | Eingeleitet | Barclays | Equal Weight |
2023-02-02 | Fortgesetzt | B. Riley Securities | Buy |
2022-11-01 | Eingeleitet | Stifel | Buy |
2022-07-15 | Eingeleitet | SVB Leerink | Outperform |
2021-10-18 | Fortgesetzt | B. Riley Securities | Buy |
2021-04-13 | Eingeleitet | RBC Capital Mkts | Outperform |
2019-01-03 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Optimizerx Corp Aktie (OPRX) Neueste Nachrichten
Should you wait for a breakout in OptimizeRx CorporationJobs Report & Fast Entry Momentum Trade Alerts - Newser
Relative strength of OptimizeRx Corporation in sector analysisOil Prices & Precise Buy Zone Identification - Newser
What Fibonacci levels say about OptimizeRx Corporation reboundIndex Update & Free Technical Confirmation Trade Alerts - Newser
How institutional ownership impacts OptimizeRx Corporation stockMarket Growth Summary & Consistent Profit Focused Trading Strategies - Newser
Best Growth Stocks to Buy for September 3rd - Zacks Investment Research
Real time scanner hits for OptimizeRx Corporation explainedTrend Reversal & Daily Volume Surge Signals - Newser
Is it time to cut losses on OptimizeRx CorporationQuarterly Earnings Report & Verified Trade Idea Suggestions - Newser
Can OptimizeRx Corporation recover in the next quarter2025 Historical Comparison & Reliable Volume Spike Alerts - Newser
Real time breakdown of OptimizeRx Corporation stock performanceQuarterly Trade Review & Breakout Confirmation Trade Signals - Newser
Will OptimizeRx Corporation continue its uptrendInsider Buying & Long-Term Capital Growth Strategies - Newser
Can OptimizeRx Corporation outperform in the next rallyMarket Trend Review & Verified Short-Term Plans - khodrobank.com
Real time alert setup for OptimizeRx Corporation performanceJuly 2025 WrapUp & Fast Gain Stock Tips - Newser
Real time pattern detection on OptimizeRx Corporation stockQuarterly Growth Report & AI Forecast for Swing Trade Picks - Newser
What Makes OptimizeRx Corp. (OPRX) a Strong Momentum Stock: Buy Now? - sharewise.com
OptimizeRx Corp. (OPRX) Shows Strong Momentum, A Strong Buy Candidate - AInvest
Published on: 2025-09-03 01:47:39 - Newser
How to escape a deep drawdown in OptimizeRx CorporationTrade Entry Report & Free Daily Entry Point Trade Alerts - Newser
What indicators show strength in OptimizeRx Corporation2025 Market Overview & Reliable Volume Spike Alerts - Newser
Chart overlay techniques for tracking OptimizeRx Corporation2025 EndofYear Setup & Intraday High Probability Alerts - Newser
Trend analysis for OptimizeRx Corporation this weekWeekly Market Report & Daily Chart Pattern Signals - Newser
Chart based analysis of OptimizeRx Corporation trends2025 EndofYear Setup & High Return Stock Watch Alerts - Newser
Quantitative breakdown of OptimizeRx Corporation recent moveOptions Play & Reliable Entry Point Trade Alerts - Newser
What the charts say about OptimizeRx Corporation todayVolume Spike & AI Driven Stock Reports - Newser
What to expect from OptimizeRx Corporation in the next 30 days2025 EndofYear Setup & Long Hold Capital Preservation Tips - Newser
What MACD and RSI say about OptimizeRx Corporation2025 Top Decliners & Community Consensus Trade Signals - Newser
Is OptimizeRx Corporation stock bottoming outMarket Activity Report & Free Daily Entry Point Trade Alerts - Newser
Applying big data sentiment scoring on OptimizeRx Corporation2025 Analyst Calls & Safe Entry Point Identification - Newser
Short interest data insights for OptimizeRx Corporation2025 Macro Impact & Daily Volume Surge Signals - Newser
Finanzdaten der Optimizerx Corp-Aktie (OPRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Optimizerx Corp-Aktie (OPRX) Insiderhandel
Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
---|---|---|---|---|---|---|---|
Lang James Paul | Director |
Mar 14 '25 |
Buy |
7.60 |
321,408 |
2,443,761 |
389,452 |
Silvestro Stephen L | Chief Commercial Officer |
Mar 01 '25 |
Option Exercise |
0.00 |
1,928 |
0 |
121,886 |
Odence-Ford Marion | Chief Legal Officer & CHRO |
Mar 01 '25 |
Option Exercise |
0.00 |
771 |
0 |
70,544 |
KLEMA CATHY | Director |
Feb 02 '25 |
Option Exercise |
0.00 |
5,109 |
0 |
11,752 |
Odence-Ford Marion | General Counsel and CCO |
Dec 19 '24 |
Option Exercise |
0.00 |
3,927 |
0 |
28,383 |
Silvestro Stephen L | Chief Commercial Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
6,546 |
0 |
83,424 |
Besch Doug | Chief Product Officer |
Dec 19 '24 |
Option Exercise |
0.00 |
1,964 |
0 |
12,160 |
Stelmakh Edward | CFO/COO |
Dec 19 '24 |
Option Exercise |
0.00 |
5,237 |
0 |
38,603 |
FEBBO WILLIAM J | CEO |
Dec 12 '24 |
Buy |
5.01 |
20,000 |
100,220 |
601,253 |
Odence-Ford Marion | General Counsel and CCO |
Nov 08 '24 |
Option Exercise |
0.00 |
1,785 |
0 |
24,980 |
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):